Neoadjuvant atezolizumab plus chemotherapy in resectable non-small cell lung cancer (NSCLC).

被引：37
|
作者：
Shu, Catherine A.
Grigg, Claud
Chiuzan, Codruta
Garofano, Robert F.
Patel, Vijeta
Hernandez, Susana
Negri, Tiffany
Sacher, Adrian G.
Smith-Marrone, Stephanie
Stoopler, Mark
Gainor, Justin F.
Awad, Mark M.
D'Ovidio, Frank
Sonett, Joshua R.
Bacchetta, Matthew
Saqi, Anjali
Rizvi, Naiyer A.
机构：
[1] Columbia Univ, Med Ctr, New York, NY USA
[2] Dana Farber Canc Inst, Boston, MA USA
[3] Massachusetts Gen Hosp, Boston, MA USA
[4] Massachusetts Gen Hosp, Cambridge, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.8532
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8532
引用
收藏
页数：1
相关论文
共 50 条
  • [11] NEOADJUVANT CHEMOTHERAPY AND RADIOTHERAPY IN NON-SMALL CELL LUNG-CANCER (NSCLC)
    WATKIN, SW
    ERRINGTON, RD
    GREEN, JA
    WARENIUS, HM
    BRITISH JOURNAL OF CANCER, 1987, 56 (02) : 231 - 231
  • [12] Efficacy and Biomarker Analysis of Neoadjuvant Toripalimab Plus Chemotherapy in Resectable Stage IIB-IIIB Non-Small Cell Lung Cancer (NSCLC)
    Liu, B.
    Wu, N.
    Yan, S.
    Zhang, E.
    Xu, L.
    Cheng, X.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S152 - S152
  • [13] Neoadjuvant chemotherapy with gemcitabine and vinorelbine in resectable non-small-cell lung cancer (NSCLC)
    Sommers, E
    Ramnath, N
    Robinson, L
    Nwogu, C
    Tan, D
    Sharma, A
    Cantor, A
    Chiappori, A
    Williams, C
    Bepler, G
    LUNG CANCER, 2005, 49 : S96 - S97
  • [14] Neoadjuvant Immune Checkpoint Inhibitor plus Chemotherapy for Resectable Non-small Cell Lung Cancer in Real World
    Chen, C.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S579 - S580
  • [15] Chemotherapy in resectable non-small cell lung cancer
    Enriqueta Felip
    Revista de Oncología, 2004, 6 (1): : 52 - 56
  • [16] Neoadjuvant Sintilimab and Chemotherapy for Resectable Stage IIIA Non-Small Cell Lung Cancer
    Zhang, Peng
    Dai, Jie
    Sun, Fenghuan
    Xia, Haoran
    He, WenXin
    Duan, Liang
    Liu, Ming
    Zhao, Deping
    Zhu, Yuming
    Jiang, Gening
    ANNALS OF THORACIC SURGERY, 2022, 114 (03): : 949 - 958
  • [17] Neoadjuvant atezolizumab in resectable non-small cell lung cancer (NSCLC): Initial results from a multicenter study (LCMC3).
    Rusch, Valerie W.
    Chaft, Jamie E.
    Johnson, Bruce
    Wistuba, Ignacio Ivan
    Kris, Mark G.
    Lee, Jay M.
    Bunn, Paul A.
    Kwiatkowski, David J.
    Reckamp, Karen L.
    Finley, David J.
    Haura, Eric B.
    Waqar, Saiama Naheed
    Doebele, Robert Charles
    Garon, Edward B.
    Blasberg, Justin
    Nicholas, Alan
    Schulze, Katja
    Phan, See-Chun
    Gandhi, Mayank
    Carbone, David Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [18] Neoadjuvant Atezolizumab in Resectable Non-Small Cell Lung Cancer (NSCLC): Updated Results from a Multicenter Study (LCMC3)
    Rusch, V.
    Chaft, J.
    Johnson, B.
    Wistuba, I.
    Kris, M.
    Lee, J.
    Bunn, P., Jr.
    Kwiatkowski, D.
    Reckamp, K.
    Finley, D.
    Haura, E.
    Wagar, S.
    Doebele, R.
    Garon, E.
    Blasberg, J.
    Nicholas, A.
    Schulze, K.
    Phan, S.
    Gandhi, M.
    Carbone, D.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S369 - S369
  • [19] IMpower030: Phase III study evaluating neoadjuvant treatment of resectable stage II-IIIB non-small cell lung cancer (NSCLC) with atezolizumab (atezo) plus chemotherapy
    Peters, S.
    Kim, A. W.
    Solomon, B.
    Gandara, D. R.
    Dziadziuszko, R.
    Brunelli, A.
    Garassino, M. C.
    Reck, M.
    Wang, L.
    To, I.
    Sun, S. W.
    Gitlitz, B. J.
    Sandler, A.
    Rizvi, N.
    ANNALS OF ONCOLOGY, 2019, 30 : 30 - 30
  • [20] Neoadjuvant immunotherapy for resectable non-small cell lung cancer
    Xie, Hui
    Shi, Xuejun
    Wang, Guangshun
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (06): : 2521 - 2536
12345